Hepatitis C: FDA Sunday
Today on this blog it's "FDA Sunday". For the male audience last week was "NFL Sunday", so sorry you missed it.
Small Note Of No Importance: The truth is this blogger doesn't understand NFL anything, so I might have exaggerated about last Sundays article. If you're having difficulty locating the entry please email me and I will do a search resulting with no actual information, Thank you
A company can't sell their product unless they find an audience, but how can they do that, other then advertising? They create a website projecting a false impression of authenticity by peppering the site with information and or health advice. On some of these sites they cite a case study, completely void of any substantial credentials.
I find it discouraging and harmful that people who suffer with chronic hepatitis c are being directed by search engines to these commercial and profitable websites. However, there is assistance to sort out these dubious claims. On the FDA's website the public can access warning letters discharged to the owners of these websites, supplied by the CDER Freedom of Electronic Information office. The information listed below is only a sampling of what is available, for additional violations see the FDA's website .
WASHINGTON—FDA issued a warning letter to Nature’s Health Co. LLC, Salt Lake City, in late September, after the agency determined the company was promoting several of its dietary supplements on its website using health claims that cause the products to be considered drugs. According to the agency, a range of products carry therapeutic claims that position the products to be used in the cure, mitigation, treatment or prevention of disease.
For example, products Cardiac Balance I and II and Notoginseng are promoted under a subhead “Stroke & Herbs" with claims discussing control of arrhythmia, prevention of platelet aggregation, and dissolving blood clots. Personal testimonials are also included under the subhead, related to patients with diagnosed coronary artery disease who took the Cardiac Balance products for six months and “symptoms disappeared or alleviated significantly."Other sections and products include Osteoporosis and Herbs (Shark Cartilage “keeps tumors from growing"); High Blood Pressure and Herbs (rubber tree has a “relaxant effect on coronary artery"); Hepatitis A, B, C and Herbs (milk thistle seed “helps relieve symptoms of acute and chronic hepatitis, hepatocirrhosis, fatty liver, damage of liver"); Multiple Sclerosis and Herbs; Anti-Diabetes; CancerEase (Cell Balance “reduces the viability of tumors"); Parkinson Disease and Herbs; Gonorrhea and Herbs (“Baicalein can restrain the activity of Neisseria gonorrhoeae, which is the causative agent of gonorrhea"); and Urinary Balance. FDA added, “The unlawful disease treatment and prevention claims on your website were too numerous to list in this letter."FDA noted the products have not been approved as safe and effective for the referenced uses by the agency as new drugs.
Sterol Max: "has been shown to have powerful healing effects on cancer, AIDS, tuberculosis…" and "Some of the symptoms known to respond well to sterol [ingredient in the product] supplementations are: Cancer (breast, colon, prostate), Rheumatoid Arthritis, Hepatitis C, HIV…"
Aloe Ace-Max™: "important in preventing and treating arteriosclerosis, heart disease and Parkinson’s disease," "direct anti-bacterial and anti-viral effect," and "powerful healing effect on AIDS, cancer."
Pro Biotic with FOS™: "kill parasitic bacteria just like antibiotics."
Metabolic Complete™: "protection of the body against the development of cancer and heart disease."
Heart Algae™: "may significantly reduce your risk of developing heart disease and many forms of cancer."
Lightning Colloidal Silver™: "naturally anti-bacterial, anti-viral, anti-germicidal and anti-fungal."
As the products have not been recognized as safe and effective for the prevention and treatment of diseases, they are therefore positioned as "new drugs" in the eyes of FDA, which may not be marketed without prior agency approval. FDA’s warning letter noted the items are also misbranded, as the labeling fails to bear adequate directions for use.
Green tea claims triggers two FDA warning letters.
The FDA has issued two warning letters related to claims made for green tea products. One ordered Unilever Americas to stop claiming that its Lipton Green Tea 100% Naturally Caffeinated product has a significant cholesterol-lowering effect and is "a naturally rich source of antioxidants." The other ordered Cadbury Adams USA to stop claiming that its Canada Dry Sparkling Green Tea Ginger Ale was "enhanced with 200 mg of antioxidants from green tea and vitamin C."MMS is distributed on Internet sites and online auctions by multiple independent distributors. Although the products share the MMS name, the look of the labeling may vary. The product instructs consumers to mix the 28 percent sodium chlorite solution with an acid such as citrus juice. This mixture produces chlorine dioxide, a potent bleach used for stripping textiles and industrial water treatment. High oral doses of this bleach, such as those recommended in the labeling, can cause nausea, vomiting, diarrhea, and symptoms of severe dehydration. In addition, the product is often marketed with multiple health claims, relating to its purported ability to support the immune system and fight conditions ranging from the common cold to cancer.
FDA is continuing its investigation into the product, and may pursue civil or criminal enforcement actions. It also asked consumers and health care professionals to report adverse events to FDA through its MedWatch program.
At a press conference announcing the FTC action, a VISA official stated that his company took aggressive action after the number of complaints from dissatisfied customers mounted. Under VISA's regulatory program, when requests for chargebacks (forced refunds) reach 1% of sales, sellers are pressured to modify their sales practices, but the CCN case was complicated because the company changed names several times. In a subsequent interview, another VISA representative told Dr. Stephen Barrett that more than half the companies that generate excessive chargebacks sell "nutraceuticals" (dietary supplements), but VISA's regulatory activity is focused on sales practices rather than product claims.
.
Since 1997, Rader has operated a stem cell clinic, initially in the Bahamas and currently in the Dominican Republic. Last year, BBC's Panorama criticized Rader's activities. One part of the Panorama report—titled "Stem cells and miracles—described the operation of his clinic and another clinic in China operated by others. Another part—titled "MS patient: The search for 'a cure'"—shows how Rader tried to pressure a woman who had multiple sclerosis to undergo his treatment. The complete broadcast can be viewed on YouTube.
2009
Department of Health and Human Services
Public Health ServiceFood and Drug Administration
Detroit District Office 300 River PlaceDetroit, MI 48207 Telephone: (313) 393-8100FAX: (313) 393-8139
May 7, 2009
CERTIFIED MAILRETURN RECEIPT REQUEST
Jess KraftSamglo Enterprises19785 West 12 Mile Road, #827Southfield, MI 48076
This is to advise you that the Food and Drug Administration (FDA) reviewed your websites in March 2009 at the Internet addresses: http://www.nu-liver.com/ , http://www.hepatitisc-remedy.com/ , http://www.nu-liverpc.com/ and www.storesonline.com/members/459211/hepatitis-c-herbs.htm and has determined that the products “Nu-Liver” and “Nu-Liver PC” are promoted for conditions that cause the products to be drugs under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 321(g)(1)(B)]. The therapeutic claims on your websites establish that the products are drugs because they are intended for use in the cure, mitigation, treatment, or prevention of disease. The marketing of the products with these claims violates the Act.
Examples of some of the claims observed on your websites include:
Nu-Liver (http://www.nu-liver.com/ , http://www.hepatitisc-remedy.com/ , www.storesonline.com/members/459211/hepatitis-c-herbs.htm )
Under "Ingredients in 'Nu-Liver Herbal Formula":
• “Sophora Root inhibits viral replication. Lowers viral load. Protects against fibrosis. Reduces destruction of liver cells.”• “Bupleurum root is used in chronic hepatitis, enlarged liver…and reduces inflammation by inhibiting prostaglandin production.”
Under "In-Depth Review of Herbs Used in NU-LIVER":
• “Clinical trials have demonstrated that bupleurum is a safe and effective treatment for hepatitis C and other chronic liver problems.”
Examples of some of the claims on your websites in the form of testimonials include:
• “I had suffered from fatigue for many years and discovered I had hepatitis c after a routine blood workup. I started on a regimen of interferon recommended by my doctor, but this only made me very sick. . . After going off treatment, I read as much as I could about natural ways to combat my Hep-C, and decided to try your product- Nu-Liver. What a world of difference it has made!”
Nu-Liver PC (www.hepatitisc-remedy.com, http://www.nu-liverpc.com/ )
• “What makes “PC” so special is…its ability to repair injured liver cell membranes that have been damaged from attack by internal and external toxins, especially viruses (i.e. hepatitis c and hepatitis b).
Under Licorice Root [an ingredient]:
• “[A]n acid that has proved to be both anti-bacterial, anti-viral and anti-tussive. Its anti-inflammatory action acts like the steroid ‘cortisone’, but without cortisone’s immune-suppressing side-effects.”• “Licorice . . . promotes healing of this vital organ. The herb’s anti-inflammatory properties help calm hepatitis-associated liver inflammation. It also fights the virus commonly responsible for hepatitis…”
• “'PC’ had the following liver-protective effects:
o Membrane damage was slowedo Cell death, fibrosis and fatty infiltration of the liver tissue were diminishedo Membrane integrity was conserved”
• “When “PC” was orally administered, liver cell membrane damage was slowed, and cell death, fibrosis, and fatty infiltration of the liver tissue were all diminished.
Examples of some of the claims on your websites in the form of testimonials include:
• “My liver enzymes were less than half of what they were only 3 months ago.”
Further, your websites cite a number of articles regarding the use of your products or their ingredients for treatment or prevention of hepatitis. When scientific publications are used commercially by the seller of a product to promote the product to consumers, such publications may become evidence of the product's intended use. For example, under 21 CFR 101.93(g)(2)(iv)(C), a citation of a publication or reference in the labeling of a product is considered a claim about disease treatment or prevention if the citation refers to a disease use, and if, in the context of the labeling as a whole, the citation implies treatment or prevention of a disease.
The following are examples of reference citations used to market "Nu-Liver PC" for disease treatment or prevention on your website:
• ”Iino S. Tango T, Matsushima T, Toda G. Miyake K., Hino K., Kumada H. Yasuda K, Kuroki T, Hirayama C, Suzuki H.Therapeutic effects of stronger neo- minophagen C at different doses on chronic hepatitis and liver cirrhosis.Hepatol Res. 2001 Jan 1;19(1):31-40.”
The reference citations and other claims are supplemented by metatags used to bring consumers to your websites through Internet searches. Examples of these metatags include “liver disease treatment,” hepatitis C treatment,” “hepatitis C remedy,” “hepatitis remedy” and “liver disease remedy.”
Your products are not generally recognized as safe and effective for the above referenced uses and therefore, the products are “new drugs” under section 201(p) of the Act [21 U.S.C. § 321(p)]. New drugs may not be legally marketed in the U.S. without prior approval from FDA as described in section 505(a) of the Act [21 U.S.C. § 355(a)]. FDA approves a new drug on the basis of scientific data submitted by a drug sponsor to demonstrate that the drug is safe and effective.
The above violations are not meant to be an all-inclusive list of deficiencies in your products and their labeling. It is your responsibility to ensure that products marketed by your firm comply with the Act and its implementing regulations. We advise you to review your websites, product labels, and other labeling and promotional materials for your product to ensure that the claims you make for your products do not cause them to violate the Act.
You should take prompt action to correct the violations described above and prevent their future recurrence. Failure to do so may result in enforcement action without further notice. The Act authorizes the seizure of illegal products and injunctions against manufacturers and distributors of those products [21 U.S.C. §§ 332 and 334].
Please notify this office, in writing, within fifteen (15) working days of the receipt of this letter, as to the specific steps you have taken to correct the violations noted above and to assure that similar violations do not occur. Include any documentation necessary to show that correction has been achieved. If corrective actions cannot be completed within fifteen working days, state the reason for the delay and the time within which the corrections will be completed.
Your response should be directed to Mr. Steven B. Barber, Director, Compliance Branch, 300 River Place, Suite 5900, Detroit, MI 48207. If you have any questions, you may contact Mr. Barber at 313-393-8110.
Sincerely,
/S/
Joann M. GivensDistrict DirectorDetroit District Office
Cc:Jesse KraftSamglo Enterpriises



November 14, 2010 11:12 PM
I saw nfl sunday,lol